Clinical Trial Update: Peripheral Blood Stem Cell Transplantation From Family Haploidentical Donors in Patients With Myelodysplastic Syndrome and Acute Leukemia Under Primary Prophylaxis With Posaconazole [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating peripheral blood stem cell transplantation from family haploidentical donors in patients with myelodysplastic syndrome and a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fungal Infection
• Graft-versus-host Disease
• Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• POSACONAZOLE (POSACONAZOLE)

Snippet

Sponsor: Ciceri Fabio | Conditions: Transplant-Related Hematologic Malignancy, Leukemia, Acute | Phase 2 | Status: COMPLETED